Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Lung Cancer Chemoprevention in Smokers
NCT00981201Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2001
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in lung cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2001; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00981201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981201.